The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125744122 12574412 2 F 20150625 20160912 20160720 20160921 EXP CA-GLAXOSMITHKLINE-CA2016GSK102486 GLAXOSMITHKLINE 80.82 YR F Y 0.00000 20160921 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125744122 12574412 1 PS VOLTAREN DICLOFENAC SODIUM 1 Topical UNK, QD 22122 CREAM QD
125744122 12574412 2 SS JAKAFI RUXOLITINIB 1 Oral 10 MG, BID N 0 10 MG TABLET BID
125744122 12574412 3 SS JAKAFI RUXOLITINIB 1 Oral 3 DF, TID N 0 3 DF TABLET TID
125744122 12574412 4 SS JAKAFI RUXOLITINIB 1 Oral 2 DF, BID N 0 2 DF TABLET BID
125744122 12574412 5 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, BID N 0 5 MG TABLET BID
125744122 12574412 6 SS JAKAFI RUXOLITINIB 1 Oral 15 MG, 1D N 0 15 MG TABLET QD
125744122 12574412 7 SS JAKAFI RUXOLITINIB 1 Oral 20 MG, 1D N 0 20 MG TABLET QD
125744122 12574412 8 SS JAKAFI RUXOLITINIB 1 Oral 15 MG, 1D N 0 15 MG TABLET QD
125744122 12574412 9 SS JAKAFI RUXOLITINIB 1 Oral 5 MG, BID N 0 5 MG TABLET BID
125744122 12574412 10 C LIPITOR ATORVASTATIN CALCIUM 1 U 0
125744122 12574412 11 C ASA ASPIRIN 1 U 0
125744122 12574412 12 C CALCIUM CALCIUM 1 U 0
125744122 12574412 13 C CITALOPRAM CITALOPRAM HYDROBROMIDE 1 U 0
125744122 12574412 14 C CELEBREX CELECOXIB 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125744122 12574412 1 Arthritis
125744122 12574412 2 Myelofibrosis

Outcome of event

Event ID CASEID OUTC COD
125744122 12574412 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125744122 12574412 Abdominal distension
125744122 12574412 Abdominal pain
125744122 12574412 Anaemia
125744122 12574412 Arthralgia
125744122 12574412 Contusion
125744122 12574412 Drug ineffective
125744122 12574412 Dry mouth
125744122 12574412 Fatigue
125744122 12574412 Flatulence
125744122 12574412 Haemoglobin decreased
125744122 12574412 Increased appetite
125744122 12574412 Initial insomnia
125744122 12574412 Loss of consciousness
125744122 12574412 Muscle spasms
125744122 12574412 Neuralgia
125744122 12574412 Pain
125744122 12574412 Pain in extremity
125744122 12574412 Peripheral swelling
125744122 12574412 Peripheral vascular disorder
125744122 12574412 Platelet count decreased
125744122 12574412 Pruritus
125744122 12574412 Renal pain
125744122 12574412 Vascular rupture
125744122 12574412 Vomiting
125744122 12574412 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125744122 12574412 2 20130815 0
125744122 12574412 5 20131126 0